Healthcare specialist Johnson & Johnson MSD Consumer Pharmaceuticals signed a deal which sees its Daktarin athlete’s foot treatment brand continue as an official partner and product of the organisation.
UK Athletics development director and deputy chief executive Adam Walker said: “We are delighted that Daktarin are to continue their support for UK Athletics and our development programmes. We are keen to further extend our strong partnership and look forward to a successful three years."
The deal was agreed through UK Athletics’ commercial partners, Fast Track.
